SCPHARMACEUTICALS INC. Proceeds from Common Stock Issued
SCPHARMACEUTICALS INC. reported Proceeds from Common Stock Issued of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2025-03-19
- SCPHARMACEUTICALS INC. proceeds from issuance of common stock for the quarter ending 2023-12-31 was $0.00.
- SCPHARMACEUTICALS INC. proceeds from issuance of common stock for the quarter ending 2023-09-30 was $0.00.
- SCPHARMACEUTICALS INC. proceeds from issuance of common stock for the quarter ending 2023-06-30 was $334.00K.
- SCPHARMACEUTICALS INC. proceeds from issuance of common stock for the quarter ending 2023-03-31 was $13.70M.
- SCPHARMACEUTICALS INC. proceeds from issuance of common stock for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- SCPHARMACEUTICALS INC. proceeds from issuance of common stock for fiscal 2023 was $14.04M, a 1153.39% increase from fiscal 2022.
- SCPHARMACEUTICALS INC. proceeds from issuance of common stock for fiscal 2022 was $1.12M.
- SCPHARMACEUTICALS INC. proceeds from issuance of common stock for fiscal 2020 was $10.39M, a 161.46% increase from fiscal 2019.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-19 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $0.00 derived: sum of 2 quarters · filed 2025-03-19 | $334.00K derived: sum of 3 quarters · filed 2025-03-19 | $14.04M 10-K · filed 2025-03-19 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $334.00K derived: sum of 2 quarters · filed 2024-11-13 | $14.04M 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $334.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $14.04M 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | $13.70M 10-Q · filed 2024-05-14 | ||||
| 2022-12-31 | $1.12M 10-K · filed 2024-03-13 | ||||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $0.00 derived: sum of 2 quarters · filed 2022-03-22 | $0.00 derived: sum of 3 quarters · filed 2022-03-22 | $10.39M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $10.39M 10-Q · filed 2021-11-09 | $14.29M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $10.39M 10-Q · filed 2021-08-11 | $14.29M derived: sum of 3 quarters · filed 2021-08-11 | ||
| 2020-03-31 | $10.39M 10-Q · filed 2021-05-12 | $14.29M derived: sum of 2 quarters · filed 2021-05-12 | |||
| 2019-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $3.97M 10-K · filed 2021-03-23 | |||
| 2019-09-30 | $70.00K 10-Q · filed 2020-11-16 | $259.00K 10-Q · filed 2019-11-12 | |||
| 2018-12-31 | -$4.00K 10-K · filed 2019-03-21 | ||||
| 2017-12-31 | $92.71M 10-K · filed 2019-03-21 |